GEN

Xcellerex to Develop Single-Use Manufacturing Technology for Humacyte’s Vascular Grafts

Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...
FiercePharma

Xcellerex, Humacyte take on regenerative medicine

Disposable bioprocessing technology is taking a step forward in a deal between platform- and service-provider Xcellerex and extracellular matrix tissue-maker Humacyte. Xcellerex will scale up ...
FierceBiotech

Xcellerex and Humacyte Announce Collaboration to Develop Single-use Manufacturing Technology for Growth of Vascular Grafts for T

Partnership will enable rapid, cost-effective, production of novel Humacyte vascular grafts for transplantation utilizing Xcellerex's XDR single-use technologies MARLBOROUGH, Mass. & RESEARCH TRIANGLE ...
GEN

Disposable Bioreactors Enter Mainstream

Single-Use Systems Slowly but Surely Gaining Acceptance in Critial Unit Operations Disposable bioreactors have become the vanguard of single-use processing, a litmus test of sorts for the acceptance ...
FierceBiotech

PRESS RELEASE: Xcellerex Raises $31 Million in Series C Financing

Xcellerex, Inc. announced today that it has raised $31 million in a Series C financing to advance the development and commercialization of its proprietary FlexFactory(TM) manufacturing system and ...